Estee Lauder's stock surged 5.02% during intraday trading, driven by the company's release of better-than-expected fiscal third-quarter results and robust growth in the China market.
The company reported Q3 FY2026 net sales of $3.71 billion, surpassing market expectations of $3.69 billion, representing a 5% year-over-year increase with 2% organic growth. Mainland China delivered high single-digit growth, marking five consecutive quarters of market share gains, with products like La Mer Miracle Eye Cream and the Estee Lauder Re-Nutriv Collagen series serving as core growth engines.
Investor confidence was further bolstered by the company's preliminary FY2027 guidance projecting 3%-5% organic sales growth and operating margins of 12.5%-13%, indicating a positive long-term trajectory for the cosmetics giant.
Comments